Showing 18,841 - 18,860 results of 36,983 for search '(( significant decrease decrease ) OR ( significant ((clinical disease) OR (linear decrease)) ))', query time: 0.61s Refine Results
  1. 18841
  2. 18842
  3. 18843
  4. 18844
  5. 18845

    Table 1_Epidemiology, clinical outcomes, and treatment patterns of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation in China: a scoping review and... by Ren Lin (4787616)

    Published 2025
    “…This review summarized the epidemiology, clinical outcomes, and treatment patterns of CMV infection among allo-HSCT recipients in China.…”
  6. 18846

    Flow diagram of included/excluded studies. by Mobin Ghazaiean (14440743)

    Published 2025
    “…<div><p>Background</p><p>The current study sought to determine the prevalence of elevated estimated pulmonary artery systolic pressure (ePASP) in clinically stable children and adults with sickle cell disease)SCD(worldwide.…”
  7. 18847

    Data Sheet 1_Mitigating inflammation and fibrosis: the therapeutic potential of quercetin liposomes in COPD.docx by Changfeng Yin (4391704)

    Published 2024
    “…Introduction<p>Chronic obstructive pulmonary disease (COPD) is a disease with severe therapeutic obstacles and high worldwide death rate. …”
  8. 18848

    Table 1_Impact of mean arterial pressure on reproductive endocrine characteristics in infertile patients with polycystic ovary syndrome: a secondary analysis of a randomized clinic... by Baichao Shi (22261375)

    Published 2025
    “…</p>Methods<p>A total of 1,000 PCOS subjects were enrolled in the clinical trial project of Acupuncture and Clomiphene in the treatment of PCOS infertility patients (PCOSAct). …”
  9. 18849

    Table 2_A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networ... by Alexander Pine (22442629)

    Published 2025
    “…Pathway enrichment analysis revealed increasing enrichment with rising statistical significance of thrombosis, complement, neutrophil and other innate and adaptive immune activation, as well as extracellular matrix (ECM) organization with increasing clinical severity, suggesting a model of progressive thromboinflammation in evolution of APS from NoAPS to TAPS and MAPS.…”
  10. 18850

    Table 1_A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networ... by Alexander Pine (22442629)

    Published 2025
    “…Pathway enrichment analysis revealed increasing enrichment with rising statistical significance of thrombosis, complement, neutrophil and other innate and adaptive immune activation, as well as extracellular matrix (ECM) organization with increasing clinical severity, suggesting a model of progressive thromboinflammation in evolution of APS from NoAPS to TAPS and MAPS.…”
  11. 18851

    Table 3_A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networ... by Alexander Pine (22442629)

    Published 2025
    “…Pathway enrichment analysis revealed increasing enrichment with rising statistical significance of thrombosis, complement, neutrophil and other innate and adaptive immune activation, as well as extracellular matrix (ECM) organization with increasing clinical severity, suggesting a model of progressive thromboinflammation in evolution of APS from NoAPS to TAPS and MAPS.…”
  12. 18852

    Table 4_A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networ... by Alexander Pine (22442629)

    Published 2025
    “…Pathway enrichment analysis revealed increasing enrichment with rising statistical significance of thrombosis, complement, neutrophil and other innate and adaptive immune activation, as well as extracellular matrix (ECM) organization with increasing clinical severity, suggesting a model of progressive thromboinflammation in evolution of APS from NoAPS to TAPS and MAPS.…”
  13. 18853

    Data Sheet 1_Effectiveness and safety of magnetic resonance–guided unilateral focused ultrasound subthalamotomy for Parkinson’s disease: a systematic review and meta-analysis of pr... by Bo Cheng (1371330)

    Published 2025
    “…Unilateral FUS-STN significantly reduced the Movement Disorders Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Part III scores for the treated hemibody in both the off-medication [MD = −11.01, 95% CI (−12.23, −9.80), p < 0.001] and on-medication states [MD = −6.51, 95% CI (−7.57, −5.42), p < 0.001]. …”
  14. 18854

    Image 1_Cerebral small vessel disease as a possibly immune-related adverse event of immunotherapy in lung cancer patients: a retrospective study.tif by Na Wu (240778)

    Published 2025
    “…Background<p>This clinical study aims to investigate the incidence of cerebral small vessel disease (CSVD) in lung cancer patients treated with ICIs and to analyze its risk factors by comparing the clinical features and laboratory tests in ICIs-treated lung cancer patients with or without CSVD.…”
  15. 18855

    Data Sheet 1_A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical fin... by Steven P. Treon (1319286)

    Published 2025
    “…In cohort 1, respiratory failure-free survival and the estimated rates of not returning to breathing room air by day 28 were not significantly different between treatments. Importantly, serological response to coronavirus disease 2019 (COVID-19) was not impacted by zanubrutinib. …”
  16. 18856

    Data Sheet 1_Association between the depression and cardiovascular risk in arthritis patients: a prospective cohort study from the CHARLS database.docx by Xiaoyuan Tian (9641737)

    Published 2025
    “…Objective<p>To investigate the association between depression and cardiovascular disease (CVD) risk in arthritis patients and evaluate the modifying role of systemic inflammation.…”
  17. 18857
  18. 18858
  19. 18859
  20. 18860